Your search returned 24 studies. (Get alerts for new studies):
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breas
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Peritoneal Cancer - Breast Carcinoma
2 Locations available
- WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
1 Location available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer - Peritoneum Tumors
1 Location available
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer - Epithelial Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Conditions: Recurrent Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
6 Locations available
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Conditions: Adenocarcinoma of the Ovary
3 Locations available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
Conditions: Ovarian Neoplasms
1 Location available
- Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
4 Locations available
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4 - Epithelial Ovarian Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
Conditions: Primary Peritoneal Carcinoma - Ovarian Carcinoma - Fallopian Tube Carcinoma
1 Location available
- Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
Conditions: Ovarian Carcinoma
4 Locations available
- Beta-Blocker / Ovarian
Conditions: Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
Conditions: Ovarian Cancer
1 Location available
- A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ov
Conditions: Ovarian Epithelial Carcinoma
1 Location available
- Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
|